why choose us

First received: June 10, 2024

Clinical Trial: Real-life-persistence to Antifibrotic Treatments

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Idiopathic Pulmonary Fibrosis

Study Type: OBSERVATIONAL


Official Title: Real-life-Persistence to Antifibrotic Treatments

Brief Summary: This study will help to better understand the persistence rate to antifibrotic (AF) treatment in real life in France and to identify potential areas for improvement by investigating the factors associated with a non-persistence rate to AF treatment.Primary objective of the study is to measure the percentage of patients still treated up to 30 months after AF treatment initiation.

Read more